Nanoformulated PDRN Improves Anti‐Inflammatory and Wound Healing Activities
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.202500373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Ji-Hye Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, College of Medical Science, Soonchunhyang University, Asan, Chungnam, Republic of Korea. Hauptthemen laut MEDLINE: Wound Healing, Nanoparticles, Anti-Inflammatory Agents, Polydeoxyribonucleotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF), Soonchunhyang University.
Themen: Wundversorgung
Abstract (Originalsprache)
Polydeoxyribonucleotide (PDRN), a bioactive DNA fragment, has been known to promote anti‐inflammatory responses and wound healing primarily via adenosine A 2 A receptor activation. However, low molecular weight PDRN can undergo rapid degradation, limiting its sustained therapeutic efficacy. In this study, we developed a scalable method to produce high‐purity, and low molecular weight PDRN ( c.a . 325 bp) from calf thymus DNA via physical fragmentation. To enhance its stability and delivery, PDRN was encapsulated in poly(lactic‐co‐glycolic acid) (PLGA) to form PDRN/PLGA nanoparticles, yielding uniform and spherical particles (336 ± 43 nm). These nanoparticles exhibited excellent colloidal stability and biodegradability (38.3% over 14 days), with sustained PDRN release (88.39% over 14 days). Moreover, the nanoformulation effectively protected PDRN from thermal, acidic, enzymatic, and UV degradation. The PDRN/PLGA nanoparticles, which exhibited no cytotoxicity or hemolysis, demonstrated superior anti‐inflammatory and wound‐healing efficacy compared to free PDRN. In an in vitro lipopolysaccharide (LPS)‐induced inflammatory wound model, they significantly accelerated wound closure compared to both LPS‐treated and untreated controls. These results suggest that nanoformulation effectively protects low molecular weight PDRN, thereby significantly enhancing its therapeutic activity and underscore the potential of PDRN/PLGA nanoparticles as a stable and effective platform for the regeneration of skin inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, College of Medical Science, Soonchunhyang University, Asan, Chungnam, Republic of Korea.
- Department of Medical Science, College of Medical Science, Soonchunhyang University, Asan, Chungnam, Republic of Korea.
ORCID-Profile: Ji-Hye Kang, Min Jeong Jeon, Sung-Eun Kim
Förderung
- National Research Foundation of Korea (NRF)
- Soonchunhyang University
Zitieren
APA
Kang, J. H., Jeon, M. J., Kim, S. E., Hwang, W. K., & Lee, M. Y. (2026). Nanoformulated PDRN Improves Anti‐Inflammatory and Wound Healing Activities. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500373
Vancouver
Kang JH, Jeon MJ, Kim SE, Hwang WK, Lee MY. Nanoformulated PDRN Improves Anti‐Inflammatory and Wound Healing Activities. Macromolecular Bioscience. 2026. doi:10.1002/mabi.202500373
BibTeX
@article{Kang2026,
author = {Kang, Ji-Hye and Jeon, Min Jeong and Kim, Sung-Eun and Hwang, Won Kyung and Lee, Mi-Young},
title = {Nanoformulated PDRN Improves Anti‐Inflammatory and Wound Healing Activities},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.202500373}
}
EUVIMED